InvestorsHub Logo
Followers 2
Posts 1472
Boards Moderated 0
Alias Born 07/20/2016

Re: ignatiusrielly35 post# 100145

Monday, 07/01/2019 4:53:42 PM

Monday, July 01, 2019 4:53:42 PM

Post# of 108192
I think data from NEO and HOT will accrue quicker than AXAL. Based on what I've read NEO/HOT show a fairly rapid immune response. Now, if that can equate to efficacy somebody might be interested in partnering, especially to pharma with PD-1 and PD-L1 inhibitors. IMHO
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ADXS News